BDBM35804
| 74 | 1 | 12 | 18 | 0 | 0 | 0 | 0 | - Adenosine A1 receptor
- Adenosine A2 receptor
- Adenosine Receptors A2a (A2a)
- Adenosine receptor A1
- Adenosine receptor A2
- Adenosine receptor A2a and A3
- Adenosine receptor A2b
- Adenosine receptor A3
| - (CGS21680) 3-(4-{2-[6-Amino-9-(5-ethylcarbamoylmethyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-ylamino]-ethyl}-phenyl)-propionic acid
- 2-[4-(2-carboxyethyl)-phenethylamino]-5''''-N-ethylcarboxamidoadenosine
- 2-[4-(2-carboxyethyl)phenethylamino]-5''''-N-ethylcarboxamidoadenosine
- 2-p-(2-carboxyethyl)phenethylamino-5''''-N-ethylcarboxamidoadenosine
- 3-(4-(2-(6-amino-9-((2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-tetrahydrofuran-2-yl)-9H-purin-2-ylamino)ethyl)phenyl)propanoic acid
- 3-(4-(2-(6-amino-9-((2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-ylamino)ethyl)phenyl)propanoic acid
- 3-(4-{2-[6-Amino-9-((2R,3R,4S,5S)-5-ethylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-ylamino]-ethyl}-phenyl)-propionic acid
- CGS 21680
- CGS-21680
- CHEMBL331372
- [3H]-CGS 21680
|
BDBM520
| 52 | 31 | 2 | 0 | 1 | 1 | 0 | 1 | - ATP-binding cassette sub-family G member 2
- Adrenergic Alpha
- Cytochrome P450 1A
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Cytochrome P450 3A5 (CYP3A5)
- HIV-1 Protease
- HIV-1 Protease A Subtype
- HIV-1 Protease A Subtype Mutant (V82F/I84V)
- HIV-1 Protease AE
- HIV-1 Protease AE Mutant (V82F)
- HIV-1 Protease AE-P
- HIV-1 Protease AE-P Mutant (F82V)
- HIV-1 Protease B Subtype
- HIV-1 Protease B Subtype Mutant (V82F)
- HIV-1 Protease B Subtype Mutant (V82F/I84V)
- HIV-1 Protease C Subtype
- HIV-1 Protease C Subtype Mutant (V82F/I84V)
- HIV-1 Protease Mutant (A71V)
- HIV-1 Protease Mutant (D30N)
- HIV-1 Protease Mutant (D30N/A71V)
- HIV-1 Protease Mutant (D30N/M36I)
- HIV-1 Protease Mutant (D30N/M36I/A71V)
- HIV-1 Protease Mutant (L10I/L90M)
- HIV-1 Protease Mutant (M36I)
- HIV-1 Protease Mutant (M36I/A71V)
- HIV-1 Protease Mutant (M46I/I54V)
- HIV-1 Protease Mutant (V82A/I84V)
- HIV-1 Protease Mutant (V82F/I84V)
- HIV-1 Protease Mutant M1 (L10I, G48V, I54V, L63P, V82A)
- HIV-1 Protease Mutant M2 (D30N, L63P, N88D)
- HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M)
- HIV-1 Protease Mutant V6
- HIV-1 Protease Mutant V6(46)
- HIV-1 Protease Mutant V6(46/54/84)
- HIV-1 Protease Mutant V6(46/84)
- HIV-1 Protease Mutant V6(54)
- HIV-1 Protease Mutant V6(54/84)
- HIV-1 Protease Mutant V6(84)
- HIV-1 Protease Mutant, A-1
- HIV-1 Protease Mutant, ANAM-11
- HIV-1 Protease Mutant, MDR-HM
- HIV-1 Protease Mutant, MDR-QM
- HIV-1 Protease Mutant, NAM-10
- HIV-1 protease
- Human immunodeficiency virus type 1 protease
- Multidrug and toxin extrusion protein 1
- Multidrug and toxin extrusion protein 2
- P-glycoprotein (P-gp)
- P-glycoprotein 1
- P-glycoprotein 1 and 3 (MDR1a/MDR1b)
- Solute carrier family 22 member 2
- Solute carrier family 22 member 3
- Solute carrier organic anion transporter family member 1B1 (OATP1B1)
- Solute carrier organic anion transporter family member 1B3 (OATP1B3)
- Solute carrier organic anion transporter family member 2B1
| - 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate
- ABT-538
- CHEMBL163
- Norvir
- RTV
- Ritonavir
|